The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control.
about
Atypical IκB proteins - nuclear modulators of NF-κB signalingIkappaBalpha and IkappaBalpha /NF-kappa B complexes are retained in the cytoplasm through interaction with a novel partner, RasGAP SH3-binding protein 2Characterization of Spi-B, a transcription factor related to the putative oncoprotein Spi-1/PU.1AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomasRespiratory syncytial virus-inducible BCL-3 expression antagonizes the STAT/IRF and NF-kappaB signaling pathways by inducing histone deacetylase 1 recruitment to the interleukin-8 promoterIdentification and characterization of BCL-3-binding protein: implications for transcription and DNA repair or recombinationI kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA bindingBCL3 encodes a nuclear protein which can alter the subcellular location of NF-kappa B proteinsStimulation of CD30 in anaplastic large cell lymphoma leads to production of nuclear factor-kappaB p52, which is associated with hyperphosphorylated Bcl-3Cloning of a differentially expressed I kappa B-related proteinA novel NF-kappa B complex containing p65 homodimers: implications for transcriptional control at the level of subunit dimerizationBCL3 is induced by IL-6 via Stat3 binding to intronic enhancer HS4 and represses its own transcriptionInteraction between hnRNPA1 and IkappaBalpha is required for maximal activation of NF-kappaB-dependent transcription.The G9a gene in the human major histocompatibility complex encodes a novel protein containing ankyrin-like repeatsCrystal structure of the ankyrin repeat domain of Bcl-3: a unique member of the IkappaB protein family.The NF-kappa B precursor p105 and the proto-oncogene product Bcl-3 are I kappa B molecules and control nuclear translocation of NF-kappa BThe bcl-3 proto-oncogene encodes a nuclear I kappa B-like molecule that preferentially interacts with NF-kappa B p50 and p52 in a phosphorylation-dependent mannerImpaired B cell development and function in the absence of IkappaBNSNF-kappa B p100 (Lyt-10) is a component of H2TF1 and can function as an I kappa B-like moleculeAn analysis of vertebrate mRNA sequences: intimations of translational controlRegulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factorsSignal-dependent translation of a regulatory protein, Bcl-3, in activated human plateletsControl of NF-kappa B transcriptional activation by signal induced proteolysis of I kappa B alphaT cell leukemia-associated human Notch/translocation-associated Notch homologue has I kappa B-like activity and physically interacts with nuclear factor-kappa B proteins in T cellsNF-κB, the first quarter-century: remarkable progress and outstanding questionsNF-κB regulation: lessons from structuresBcl3, an IkappaB protein, as a novel transcription coactivator of the retinoid X receptorEstrogen withdrawal-induced NF-kappaB activity and bcl-3 expression in breast cancer cells: roles in growth and hormone independenceTransgenic targeting of a dominant negative corepressor to liver blocks basal repression by thyroid hormone receptor and increases cell proliferationBCL-3 expression promotes colorectal tumorigenesis through activation of AKT signallingCharacterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loopSignal-induced degradation of I(kappa)B(alpha): association with NF-kappaB and the PEST sequence in I(kappa)B(alpha) are not requiredThe structure of the NF-kappa B p50:DNA-complex: a starting point for analyzing the Rel family.The tumor promoter and NF-κB modulator Bcl-3 regulates splenic B cell development.Characterization of Chlamydomonas reinhardtii zygote-specific cDNAs that encode novel proteins containing ankyrin repeats and WW domains.Basal cancer cell survival involves JNK2 suppression of a novel JNK1/c-Jun/Bcl-3 apoptotic network.Nuclear localization of IkappaB alpha is mediated by the second ankyrin repeat: the IkappaB alpha ankyrin repeats define a novel class of cis-acting nuclear import sequences.Gene array analysis reveals changes in peripheral nervous system gene expression following stimuli that result in reactivation of latent herpes simplex virus type 1: induction of transcription factor Bcl-3.Active chromatin domains are defined by acetylation islands revealed by genome-wide mappingMouse mammary tumor gene int-3: a member of the notch gene family transforms mammary epithelial cells.
P2860
Q21245512-CFE387DA-0277-40E7-99F8-76E78E98B292Q24290171-0BA26772-FE99-47DA-9DF7-13876A16F5C5Q24293686-97B5C2B4-DA9D-4DC1-B6BC-2673035FC303Q24294176-FF7B4631-861D-4528-8EA6-540FCDDB6925Q24296927-912C6366-9277-4550-A3D1-902DB2A146AFQ24301013-C5D61359-FA3E-49BB-814A-6901A2EBABB6Q24307786-811E2E60-12B8-46DE-B0A1-43C16E1D5DEFQ24315909-480B3BCA-18EE-4A07-9F42-721CA79EF23FQ24316194-2161A84A-A027-474C-82B6-FB9DBC70380FQ24316435-1726F532-D3E7-49BA-AE0E-12BFA584E272Q24320246-C1ED6859-4E91-447A-923C-3AB16DB7DE3FQ24338268-A01534C1-8558-4665-BB52-20CACED09291Q24514760-2F4659D2-8E32-4E1B-8985-51AD7ACF470DQ24527670-325F0EB3-7469-4FCC-9FA7-7249799DD450Q24535966-7C5BD0C7-77E8-48E5-A1C4-875E40FEB0F7Q24564833-66C5B9B1-502C-47D4-8499-20B14A1D805FQ24604635-F987DA54-0AE9-4BF4-8E8C-A94A37825A80Q24625466-CEBBBBC9-95F5-4D1B-996B-C9F9E4789486Q24629772-E9FF6F42-FDBF-4324-BE05-A32970A05E7EQ24642530-62774EB1-CA15-4EC2-8446-1FC1BB1C63CEQ24651506-953ADB21-CD40-45CB-ABDF-457A36C64CFDQ24675173-08A2A50E-AAF7-41FF-AE52-6B45143746E7Q24676497-DBC5DD50-572A-46F9-A364-A7D5169C8BF1Q24678251-F716C7BB-A068-458D-9015-E9F982D19528Q26822516-CD807571-D2DE-4FCE-8244-DBDA9FF77447Q26859097-97B93E52-DD02-4F1C-A14F-C0C22A8330CCQ28288617-D8AAE679-0D0A-4480-9EE5-D46E30788266Q28396413-83CA44B0-0973-4F66-8AAF-43C552A0B90BQ28594081-96344D66-E0A0-49BC-BBCE-6B9A862E31C3Q28596448-972105FF-B674-4D1B-B340-D13A2DAC1B3CQ28645865-BE81E0CA-2B09-4189-AEE6-00B9DA7EB05BQ28776784-54F9478E-5356-4E00-B29A-D77EB079B8B3Q30193224-279ECC58-A51E-423F-9F19-FC9975274148Q30560173-47E8D72F-4C0C-4714-81B7-5FE0812A3EB1Q30653751-E547D8B9-1160-4BCA-B841-27F6272AF317Q33508814-DDF916FB-6535-4E93-BDD4-52CD882370F7Q33786457-64071E7E-1557-42BB-8E0E-6B24C746453CQ33847005-647A8FF3-4BD6-4907-A02A-A710E2245E5AQ33915748-EFC24A0F-E9D1-4235-BF64-4DF26FF70B74Q33934024-64133577-2628-4D78-8CB7-BDFB65B54504
P2860
The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control.
description
1990 nî lūn-bûn
@nan
1990 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի մարտին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
The candidate proto-oncogene b ...... nation and cell cycle control.
@ast
The candidate proto-oncogene b ...... nation and cell cycle control.
@en
The candidate proto-oncogene b ...... nation and cell cycle control.
@nl
type
label
The candidate proto-oncogene b ...... nation and cell cycle control.
@ast
The candidate proto-oncogene b ...... nation and cell cycle control.
@en
The candidate proto-oncogene b ...... nation and cell cycle control.
@nl
prefLabel
The candidate proto-oncogene b ...... nation and cell cycle control.
@ast
The candidate proto-oncogene b ...... nation and cell cycle control.
@en
The candidate proto-oncogene b ...... nation and cell cycle control.
@nl
P2093
P1433
P1476
The candidate proto-oncogene b ...... nation and cell cycle control.
@en
P2093
P304
P356
10.1016/0092-8674(90)90347-H
P407
P577
1990-03-01T00:00:00Z